- Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
Paola Anna Jablonska et al, 2021, Cancers CrossRef - Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study
Lucheng ZHU et al, 2021, BMC Cancer CrossRef - Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models
Sanjay Kumar K et al, 2022, AAPS PharmSciTech CrossRef - Potential Targets and Mechanisms of Dalbergia odorifera on Treating Lung Adenocarcinoma Explored by Network Pharmacology
Zhongyv Xiong et al, 2023, International Journal of Pharmacology CrossRef - Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation—Positive Lung Cancer Cells
Paulina Skupin-Mrugalska et al, 2020, Pharmaceutics CrossRef - Selenium speciation-dependent cancer radiosensitization by induction of G2/M cell cycle arrest and apoptosis
Shiqing Nie et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef